South Africa HPV Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
South Africa · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$9.4 MnPlaceholder estimate
Estimate 2025$10.7 Mn0.7% of the global market
Projected 2034$33.4 Mn 212.6%Adds $22.7 Mn over 9 forecast years
CAGR 2025–203413.5%Faster than 78% of 173 Medical Devices markets here
Key players5
South Africa is 0.66% of the global market.
In Africa, the largest is South Africa (this report) at $10.7 Mn.
Fastest growing: South Africa (this report) at 13.5% a year.
South Africa ranks 1st of 3 by size in Africa.
Market size projection
South Africa
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$22.7 Mn total, 2026–2034
Year-by-year market size, 2024–2034
HPV Testing Market market size by year, South Africa
Year
Market size
Change that year
Since 2025
2024 (estimate)
$9.4 Mn
—
—
2025 (base)
$10.7 Mn
+$1.3 Mn
—
2026 (forecast)
$12.1 Mn
+$1.4 Mn
+13.5%
2027 (forecast)
$13.8 Mn
+$1.6 Mn
+28.8%
2028 (forecast)
$15.6 Mn
+$1.9 Mn
+46.2%
2029 (forecast)
$17.7 Mn
+$2.1 Mn
+66%
2030 (forecast)
$20.1 Mn
+$2.4 Mn
+88.4%
2031 (forecast)
$22.9 Mn
+$2.7 Mn
+113.8%
2032 (forecast)
$25.9 Mn
+$3.1 Mn
+142.6%
2033 (forecast)
$29.4 Mn
+$3.5 Mn
+175.4%
2034 (forecast)
$33.4 Mn
+$4.0 Mn
+212.6%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
3 in South AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in South Africa. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The South Africa HPV Testing Market Analysis Executive Summary
HPV testing detects human papillomavirus types that can cause cervical cancer, used for cervical screening, including self-collected samples.
Key segments of the HPV Testing market include test (HPV DNA Tests, HPV mRNA Tests and Genotyping Tests) and sample (Clinician-Collected and Self-Collected).
South Africa HPV Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
South Africa HPV Testing Market Dynamics
Market Growth Drivers
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the HPV Testing market. New products designed around women's biology and digital care are improving access.
Opportunity
Femtech, personalised care and new treatments for under-served conditions open strong growth for the HPV Testing market, especially as employers and payers add women's health benefits.
Market Restraints
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the HPV Testing market.
Competitive Landscape for HPV Testing Market in South Africa
The HPV Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for HPV Testing Market in South Africa
HPV Testing in South Africa: rules, payment and research
The South African Health Products Regulatory Authority (SAHPRA) regulates medical devices, starting with licences for the companies that make, import and sell them.[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.[2] ClinicalTrials.gov lists 3 studies on HPV Testing that are recruiting, active or about to start in South Africa.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in South Africa. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how HPV Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in South Africa.
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in HPV Testing right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
HPV Testing in context
South Africa compared
Health spending per person: 537 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in Africa.[1]
Doctors: 0.79 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in Africa.[2]
People aged 65 and over: 6.9% of people (2025). World: 10.4% of people (2025). 2nd highest of the 17 countries we cover in Africa.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
How big is the HPV Testing market in South Africa?
Placeholder estimate: about $10.7 Mn in 2025, rising to about $33.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the HPV Testing market in South Africa growing?
Placeholder estimate: about 13.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the HPV Testing market report cover?
The report splits the market by test (HPV DNA Tests, HPV mRNA Tests, Genotyping Tests), sample (Clinician-Collected, Self-Collected) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the HPV Testing market?
Key players include Roche Diagnostics, Hologic, Inc., Qiagen N.V., BD (Becton, Dickinson) and Abbott Laboratories.
What is driving the HPV Testing market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the HPV Testing market. New products designed around women's biology and digital care are improving access.
Who regulates HPV Testing in South Africa?
The South African Health Products Regulatory Authority (SAHPRA) regulates medical devices, starting with licences for the companies that make, import and sell them. Source: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
How is healthcare paid for in South Africa?
Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone. Source: National Department of Health. Checked 14 Nov 2026.
How many clinical trials on HPV Testing are running in South Africa?
3 studies are recruiting, active or about to start in South Africa, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in South Africa. Retrieved 12 Nov 2026.
How much research is published on HPV Testing?
PubMed lists 1,549 papers on HPV Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.